32,512
edits
Hinamizawa Syndrome: Difference between revisions
m
→Use as a biological weapon
No edit summary |
|||
Line 6:
Shortly after Hifumi Takano's death, his adopted granddaughter, [[Miyo Takano]], took over the research of HS. She managed to secure generous funds from [["Tokyo"]] official named [[Nomura]]. Using this money, Miyo joined with [[Kyousuke Irie]] and formed the [[Irie Institution]] and further research HS from within [[Hinamizawa]] itself.
=== Use as a biological weapon ===▼
{{anchor|H-173}}
▲=== Use as a biological weapon ===
[["Tokyo"]] decided Japan needed a threatening biological weapon to compete with the emergent nuclear powers. As a result, "Tokyo" commissioned research for both the cure and infliction of HS. In 1980, [[Miyo Takano]] developed '''H-173''', a drug designed to induce L5 symptoms on any infected person. In 1983, H-173 is used in the assassination of [[Jirou Tomitake]]{{ref|notallarcs}}.
| |||